Reaction of phthalimido alkyl acids with isopropylamine: synthesis, anti-inflammatory and antinociceptive properties by Okunrobo, Lucky O. & Usifoh, Cyril O.
 
African Journal of Biotechnology Vol. 5 (8), pp. 643-647, 18 April 2006 
Available online at http://www.academicjournals.org/AJB 






Full Length Research Paper 
 
Reaction of phthalimido alkyl acids with 
isopropylamine: synthesis, anti-inflammatory and 
antinociceptive properties 
 
Lucky O. OKUNROBO* and Cyril O. USIFOH 
 
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Benin, Benin City, Nigeria. 
 
Accepted 28 March, 2006 
 
Phthalimido alkyl acids 3-phthalimidopropionic acid (2a) and 4-phthalimidobutyric acid (2b) were 
treated with isopropylamine at room temperature using different solvents (dimethylformamide, 
dichloromethane and methanol) as the reaction medium and afforded 3-benzamido-propionic acid –2-(2-
methylethyl)-carboxamide (3), 2-benzamido-2-methylethane-2-(2-methylethyl)-carboxamide (4), and 4-
benzamido-butyric acid –2-(2-methylethyl)- carboxamide (5). Compound 4 was a dimmer that was least 
expected. Compounds 3, 4 and 5 were evaluated for antinociceptive property using acetic acid-induced 
writhing test. 4 exhibited the highest analgesic effect at 80 mg/kg it caused 88 % inhibition and was 
more pronounced than the reference drugs (indomethacin, acetylsalicylic acid and paracetamol), 3 and 
5. The anti-inflammatory activity of the compounds was also screened using carrageenan- induced rat 
paw oedema assay and 4 showed higher activity than others except the reference drug. The effects 
were dose-dependent. 
 






Non-steroidal anti-inflammatory drugs (NSAIDs) belong 
to a variety of chemical classes with no common features 
except the absence of a steroidal structure. Their primary 
effect is pain relief but also with antipyretic and anti-
inflammatory activities. Their pro-algogenic effects are 
explained by sensitization of nociceptive nerve endings to 
the stimulating effect (algogenic) of kinins (bradykinin), 
serotonin and histamine. In addition, production of 
prostanoid in the brain has a thermoregulatory effect 
(Devillier, 2001). Prostaglandins sensitize peripheral 
nerve endings and nociceptors to transmit pain signals to 
the brain and the spinal cord (Dannhardt and Kiefer, 
2001). There are over twenty NSAIDS regularly 
prescribed in the clinics with undesirable side effects 
hence the search for newer drugs (Duffy et al., 2001).   
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properties of compounds containing free carboxylic acids  
have been described previously (Vazquez et al., 1996; 
Nakamura et al., 1983); hence the basis for screening the 
compounds synthesized for antinociceptive property. The 
presence of two carbonyl groups in phthalimides 
increases the acidity of the amino hydrogen, reduces its 
nucleophilicity of both oxygen and nitrogen atoms, and 
increases the electron deficiency of carbonyl carbons. 
Thus nucleophilic addition to the carbonyl carbon atom is 
frequently encountered. The attack at the carbonyl 
carbon by nucleophilic reagents such as amine is 
possible producing ring cleavage (CO – N bond fission) 
to give diamides; hence the use of isopropylamine to 
open the phthalimidoalkyl acids.  
The aim of this work was to study the effect of 
isopropylamine on phthalimidoalkyl acids, subsequent 
opening of the phthalimido moiety and to study the 
influence of different solvents on the yield, rate of 
reaction and the product formed. The products formed 
were then evaluated for anti-inflammatory and 
antinociceptive properties.  
 




MATERIALS AND METHODS 
 
Melting points measured were uncorrected. IR spectra were 
recorded on a Buck scientific IR M500 instrument. NMR spectra 
were recorded on a Varian Gemini 200. Chemical shifts are 
reported in ppm relative to tetramethylsilane. Mass spectra were 
acquired on a Varian MAT 44S mass spectrometer operating at 
70eV. Elemental analysis agreed favourably with the calculated 
values. Analytical thin layer chromatography (TLC) was used to 
monitor the reactions.  
 
 
Synthesis of phthalimido alkyl acids (2a-b) 
 
74 g (0.5 mol) of phthalic acid anhydride and 0.5 mol of the 
respective β-alanine and GABA were refluxed in 300 ml toluene in 
the presence of 6.5 ml triethylamine for 2 h in a Dean-stark 
apparatus. The organic solvents were removed in vacuo, 70 ml of 
water and 10 ml of concentrated HCl were added and the mixture 
stirred for 30 min, filtered and dried. Recrystallization from ethanol 
yielded 3-phthalimidopropionic acid (2a), 99.9 g, 91%, mp 151-
152oC (Litt. 150-152 oC) and 4-phthalimidobutyric acid (2b), 95.5 g, 
82%, mp116-118oC (Litt. 116-117 oC).  
 
 
Synthesis of the carboxamides 
 
3-Benzamido-propionic acid –2-(2-methylethyl) carboxamide 
(3): To a solution of 3-phthalimidopropionic acid (1.0 g, 4.60 mmol) 
in 30 ml of methanol : dichloromethane (1:2) was added 
isopropylamine (0.54 g, 9.20 mmol) and stirred at room temperature 
for 3 h. The organic solvent was removed in vacuo, an oily residue 
was obtained which slowly crystalised after 5 days to give needle-
like crystals (yellowish), and recrystallized from methanol : hexane 
mixture to give compound 3 (0.74 g, 58.05%), mp 80-82 oC.                     
                                                                                                                                                                                                                                                                                                          
IR (KBr,νmax, cm-1): 3615 (NH), 3412 (OH), 1720 (COOH), 1610 
(C=O), 1516 (C-N), 770 (1,2-disubstitution). 
1H NMR (200MHz, DMSO-d6, δ): 1.15-1.12 (d, 6H, J = 6.4Hz, -2 X 
CH3), 2.35-2.17 (m, 1H, -CH-), 3.26-3.13 (q, 2H, J =6.6Hz -NH-CH2-
), 3.74-3.66 (t, 2H, J = 6.6Hz, -CH2COOH), 5.23 (brs, 1H, -OH), 
7.52-7.31 (m, 2H, Ar-H), 7.82-7.76 (m, 2H, Ar-H), 8.10  (d, 1H, J = 
7.0Hz, NH), 8.20 (t, 1H, J = 6.3Hz, NH).      
13C NMR (50MHz, DMSO-d6, δ): 22.1 (-2 X CH3), 33.5 (CH2), 34.9 
(CH2), 42.3  (-CH), 122.8, 127.6, 128.9, 132.0, 134.2, 135.9 (Ar-C), 
167.2 (C=O), 167.7(C=O), 174.6   (COOH). 
MS (m/z, 70eV): 278.0 (2%)[M+], 201.9(2), 174.1 (18), 173.0 (100), 
160.1 (44), 133.0 (21), 104.1 (38), 76.1 (25), 66.1 (8), 51.0 (9). 
Elemental Analysis: Found (%): C, 60.43; H, 6.47; N, 10.07; 
C14H18N2O4. Anal. Calcd. (%): C, 60.42; H, 6.52; N, 10.07. 
  
Benzamido - N, N - bis (2 - methylethyl) - carboxamide (4): To a 
solution of 3-phthalimido propionic acid (1.00 g, 4.56 mmol) in  8 ml 
of DMF was added isopropylamine (1.89 g, 31.93 mmol) and stirred 
at room temperature for 4 h. The reaction mixture was poured 
into10 ml of cold 2 M HCl and stirred for 5 min and 30 ml of cold 
water was then added and stirred. The precipitate formed was 
filtered and recrystallized from methanol : hexane mixture, however 
the filtrate was further extracted with dichloromethane. The organic 
phase were combined, washed with brine, dried over MgSO4   and 
evaporated under reduced pressure, which was further 
recrystallized from chloroform: hexane mixture to give a white 
needlelike crystals 4 (0.34 g, 30.27%), mp 176-178oC. IR (KBr,νmax, 
cm-1): 3611 (NH), 1649 (C=O), 1526 (C-N), 770 (1,2-disubstitution). 
1H NMR (250MHz, DMSO-d6, δ): 1.13-1.03 (d, 6H, J = 6.6Hz 2 X 
CH3), 1.40-1.38 (d, 6H, J =6.9Hz, 2 X CH3), 4.03-3.95 (sext, 1H, J = 





2H, Ar-H), 8.08 (d, 1H, J= 7.7Hz, NH). 
13C NMR (63MHz, DMSO-d6, δ): 19.8 (2 X CH3), 22.2 (2 X CH3), 
40.9 (-CH), 42.2 (-CH), 122.8, 127.6, 129.0, 131.5, 131.7, 134.3, 
136.2 (Ar-C), 167.3 (C=O), 165.8 (C=O); MS (m/z, 70eV): 248.1 
(5%)[M+], 247.0(16), 190.0(21), 177.1(28), 162.1(10), 148.1 (100), 
130.1(72), 105.1(14), 92.1(12), 77.1(10), 58.1(26). 
Elemental Analysis: Found (%): C, 67.71; H, 8.06; N, 11.49; 
C14H20N2O2. Anal. Calcd. (%): C, 67.52; H, 8.22; N, 11.08. 
 
 
4-Benzamido-butyric acid –2-(2-methylethyl) carboxamide (5): 
To a solution of 4-phthalimido butyric acid (1.5 g, 6.43 mmol) in 10 
ml of DMF was added isopropylamine (2.6 g, 45.02 mmol) and 
stirred at room temperature for 30 min. The reaction mixture was 
poured into 10 ml of cold 2 M HCl and stirred for 5 min and 30 ml of 
cold water was then added and stirred. This was then extracted 
with chloroform (3X 20 ml). The organic phase were combined, 
washed with brine, dried over MgSO4 and evaporated under 
reduced pressure, which was recrystallized from dichloromethane 
to give a white needlelike crystals 5 (1.20 g, 95.77%), mp 123-
125oC. 
 
IR (KBr,νmax, cm-1): 3743, 3616 (NH), 3418 (OH), 1721 (COOH), 
1620 (C=O), 1516 (C-N), 1390 (C=C), 770 (1,2-disubstitution). 
1H NMR (250MHz, DMSO-d6, δ): 1.09-1.12 (d, 6H, J = 6.5Hz, 2 X 
CH3), 1.63-1.80 (dd, 2H, J= 7.2Hz, -CH2-), 1.98-2.12 (q, 2H, J= 
7.2Hz, HN-CH2-), 3.10-3.20 (sext, 1H,  J= 6.5Hz, -CH), 3.52 -3.57 
(t, 2H, J= 7.1Hz, CH2COOH), 5.69 (brs, 1H, OH), 7.84-7.76 (m, 4H, 
Ar-H), 8.06-8.09 (d, 1H, J= 7.8Hz, NH), 8.40 (t, 1H, J = 7.5Hz, NH).         
13C NMR (63MHz, DMSO-d6, δ): 20.9 (-2 X CH3), 22.1 (CH2), 33.9 
(CH2), 38.4 (CH2), 42.2 (-CH), 122.8, 131.5, 134.2, 136.1(Ar-C), 
167.3(C=O), 167.8(C=O), 175.4 (COOH).         
MS (m/z, 70eV): 288.3(M+-4)(2%), 282.7(3), 216(12), 214(60), 
187.1(64), 174.1(86), 173.1(100), 160.1(98), 147.1(37), 133.1(51), 
104.1(30), 77(49), 51.1(29). 
Elemental Analysis: Found (%): C, 62.03; H, 6.99; N, 9.72; 





Swiss mice (20-25 g) and wistar rats (180-230 g) of either sex kept 
at the laboratory Animal home of the Faculty of Pharmacy, 
University of Benin, Benin City, Nigeria were used. The animals 
were maintained under standard environmental conditions and had 
free access to standard diet and water (test compounds were 
administered orally by gavage in 5% Tween 80 suspensions at 
different dose level).  Ethical approval was obtained from the 
Animals Use and Ethics Committee of the Faculty of Pharmacy, 





Anti-inflammatory activity was measured using carrageenan- 
induced rat paw oedema assay (Winter et al., 1962; Adeyemi et al., 
2002). Groups of 5 rats of both sexes (pregnant females excluded) 
were given a dose of a test compound. After 1 h, 0.1 ml, 1% 
carrageenan suspension in 0.9% NaCl solution was injected into 
the sub-plantar tissue of the right hind paw. The linear paw 
circumference was measured at hourly interval for 4 h (Bamgbose 
and Noamesi, 1981). Two groups of drug treated rats and one 
control group were used each test day; the mean paw oedema 
value for the test group being compared with its mean value for the 
control group for that day. 
Anti-inflammatory activity (Duffy et al., 2001) was measured as 
the percentage reduction in oedema level when drug was present, 
relative to control as shown in Table 2.  
 




                    Table 1. Effect of the test compounds on acetic acid-induced writhing test. 
 
Compounds Dose (mg/kg) p.o. Number of writhings (per 20 min) % Inhibition 
Control - 31.17 ± 0.79 - 
Indomethacin 10 9.37 ± 0.59** 69.94 
Acetylsalicylic acid 100 12.89 ± 1.02** 58.65 






22.61 ± 1.81 
18.25 ± 2.25** 
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2a = n = 2
















































i MeOH/CH2Cl2 ii DMF, RT iii CH2Cl2,RT Or DMF, RT  
 
Figure 1. Synthesis of phthalimido alkyl acids and carboxamides. 3-Phthalimidopropionic 
acid (2a) and 4-Phthalimidobutyric acid (2b) were treated with isopropylamine at room 
temperature using different solvents (dimethylformamide, dichloromethane and methanol) 
as the reaction medium and these further produced 3-benzamido-propionic acid-2-(2-
methylethyl)-carboxamide (3), benzamido-N,N-bis-(2-methylethyl)-carboxamide (4) and 4-
benzamido-butyric acid-2-(2-methylethyl)-carboxamide (5). 
 




                     Table 2. Carrageenan rat paw oedema anti-inflammatory activity of the test compounds. 
 
Compounds Doses mg/kg (p.o.) Change in paw 
oedema mean ± SEM 
(mm) 
% oedema inhibition 
relative to control at 
the 3rd hour 
Control 5 % Tween 80 0.3ml 4.62 ± 2.67 - 




4.40 ± 2.79 
3.30 ± 1.59* 







3.05 ± 2.01* 
2.08 ± 2.24** 







3.48 ± 2.01* 
3.01 ± 1.01* 




                                              
                       Values are mean ± S.E.M; *P< 0.05, **P< 0.001, significantly different from control, paired t- test (n=5), p.o = per oral. 
 
 
Activity = 100 – [100 x (average drug treated /average for control)]. 
Indomethacin (10 mg/kg) was administered orally as reference drug 





The methods of Koster (1959) and Adeyemi (2004) were employed. 
Group of 5 mice of both sexes (pregnant females excluded) were 
given a dose of a test compound by gavage. After one hour the 
animals were injected intraperitoneally with 0.2 ml/mouse of 0.6% 
acetic acid solution (in normal saline) and writhes were counted 
during the following 20 min. 5% Tween 80 was used as the 
negative control while acetylsalicylic acid (100 mg/kg p.o), 
paracetamol (40 mg/kg p.o) and indomethacin (10 mg/kg p.o) were 
used as reference drugs.  The total number of constrictions was 
summed for five mice in each group analgesic activity were 
recorded as the percentage inhibition of abdominal constrictions 
when drug was present compared with control group (Amir and 
Kumar, 2005)    
 
% Analgesic activity = (n – n’/n) x 100 
 
Where n = mean number of writhes of control group and n’ = mean 













The synthesis of phthalimido alkyl acids is depicted in 
scheme 1 as describedin Figure 1 (scheme 1) as 
described previously (Usifoh et al., 2001). The reaction of 
the amino acids with phthalic acid anhydride (1) with  
concomitant removal of water produced phthalimido alkyl 
acids (2a - b). When 2a was treated with isopropylamine 
in MeOH : CH2Cl2 mixture it yielded compound 3, but in 
DMF it afforded 2-Benzamido-2-methylethane-2-(2-
methylethyl)-carboxamide (4) which shows that the 
isopropylamine completely displace the aliphatic 
carboxylic acid group. This could be attributed to the fact 
that excess amine was used i.e ratio of 2a: 
isopropylamine (1:7). A unique product was obtained 
when 2b and isopropylamine (1:7) react in the presence  
of dimethylformamide (DMF) to yield compound 5 despite 
the excess amine used giving 95.77% yield but in the 
presence of dichloromethane (CH2Cl2) it afforded the 
same product 5 with a low yield (10%). In Figure 1 
(scheme 3), the aliphatic carboxylic acid was not 
replaced by the isopropylamine, which reveal that the 
number of the methylene group between the –NH- and –
COOH affects the stability of the products formed. The 
reaction time for scheme 3 was 30 min while that of 
scheme 2 (Figure 1) was 3-4 h. The rate of reaction is 
affected by the solvent used because of the varying 
abilities of solvents to solvate reagents and transition 
state. Solvation refers to specific interactions between 
solvent molecules and dissolved reagents and or 
transition state. These interactions are hydrogen bonding, 
dipole-dipole and ion-dipole interactions.Hence the 
products formed and the rate of reaction is however 





The in vivo anti-inflammatory and analgesic activity of the 
carboxamides (3, 4 and 5) were determined. Anti-
inflammatory activity was measured by means of the 
carrageenan – induced rat paw oedema. These results 
are shown in Table 2. 2-Benzamido-2-methylethane-2-(2- 
methylethyl)-carboxamide (4) at 80 mg/kg produced the 






screened, but is less active  when  compared to the 
reference drug, indomethacin, which at 10 mg/kg causes 
74% inhibition. The effect of the compounds (3, 4 and 5) 
on carrageenan induced paw oedema was most 
pronounced at the third hour of inflammatory response, 
which corresponds to the phase of prostaglandin release 
(Dannhardt and Kiefer, 2001). 
The in vivo analgesic activity of compounds 3, 4 and 5 
were determined using mouse writhing assay which is a 
useful test for evaluating mild analgesic NSAIDs and the 
result obtained are summarized in Table 1. The most 
active compound is 4, which exhibited 88.45% inhibition 
at a dose of 80 mg/kg compared to compounds 3 and 5 
and the reference drugs (indomethacin, acetylsalicylic 
acid and paracetamol) used. The percentage inhibition of 
4 increases geometrically as the concentration increases, 
which shows that it has a dose-dependent effect but this 
was not observed with compounds 3 and 5. From the 
results in Table 1, it could be deduced that not all free 
acid containing compounds have pronounced analgesic 
activity when compared to non-free acid containing 
compounds. Thus the antinociception may not 
necessarily be due to the acidic moiety present in the 
compound. From this assay it suggests that the analgesic 
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